Case Study

CaseStudy_Investment Decision Study For US Pharma SI
Evaluating Strategic Investment Opportunities
Evaluating Strategic Investment Opportunities 874 600 Vivek g

Understanding Competition, Evidence and Maturity Around Set of Upcoming Delivery Technologies . How DataZymes combined its expertise, experience and set of novel analytical frameworks to compare the maturity status of the technologies and draw a risk vs therapeutic reach comparison to support investment decision Challenge Over the last two decades, the biopharmaceutical industry has witnessed…

read more
Website Revamp_SI Case Study Continuous CI Monitoring With The DZ CI Tool
Continuous CI Monitoring
Continuous CI Monitoring 874 600 Vivek g

Monitoring competitor initiatives to enable clients develop proactive responses to potential threats. Challenge One of the top 20 biopharmaceutical company, focused on multiple indications was looking to actively monitor its IBD space and stay abreast with the latest market trends and competition. Leveraging a traditional approach of manual tracking & assessment brought several hurdles with…

read more
Website Revamp_SI Case Study Portfolio Strategy Planning_Nov 2020
Portfolio Strategy Planning
Portfolio Strategy Planning 874 600 Vivek g

Indication review and prioritization to define value inflection strategy for an early stage candidate. Challenge A top US based pharmaceutical company focusing on developing and commercializing innovative therapies for treatment of oncology, was looking to conduct due diligence in the post-PD-(L)1 landscape, to explore the market opportunity for its own early assets in this space.…

read more
CaseStudy_Sales Home Office Reporting
Enabling a Future-ready Sales Performance Monitoring Platform
Enabling a Future-ready Sales Performance Monitoring Platform 874 600 Vivek g

How our data expertise, functional expertise and technology expertise enabled a sales reporting platform. This suite covers data from all major data sources such as sales, call activity, hub performance, access, claims, audited sales, Speaker Program, Digital (NPP) promotional activities etc. Challenge A large Global Pharma major was looking to set up their field performance…

read more
A novel approach to identifying Market Potential across Geographies
A novel approach to identifying Market Potential across Geographies 874 600 Vivek g

Quantifying potential and opportunities across the geographic segments, beyond the traditional approaches. DataZymes enabled identifying clusters with maximum potential and enhance sales force messaging effectiveness Challenge The pharma client, being a medium sized company and working with limited sales force was looking at enhancing the approach to quantify potential and opportunities across the geographic segments,…

read more
CaseStudy_Marketing-Mix
Measuring the impact of Covid on OPIODS Marketing
Measuring the impact of Covid on OPIODS Marketing 874 600 Vivek g

Market Mix Modeling to understand the impact of Covid-19 for a Long Acting Opiod. Challenge As the Opioids market is booming worldwide, our client, one of the top pharmaceutical companies, wanted to achieve brand’s strategic objectives of becoming the #1 LAO (Long Acting Opioid) in the market. One of the key prospects for the company…

read more
Setting up an Effective Data Quality Platform for Pharma
Setting up an Effective Data Quality Platform for Pharma 874 600 Vivek g

Lumen TM, a complete Data Quality Platform purpose built for Pharma has helped clients improve Data Quality. Is your Data Accurate? Most companies cannot answer this question with confidence since they do not have a framework and process to measure quality of data across the Data Continuum. While syndicated data is assumed to be clean,…

read more
Improving sales through understanding patient behavior
Improving sales through understanding patient behavior 874 600 Vivek g

Integrating traditional patient studies like persistency, compliance, and length of therapy to better understand the behavior in dropping off a drug. How DataZymes combined different studies like persistency, compliance and length of therapy, handling data leakage to give better picture of patients’ behavior in longitudinal. Challenge Only one third of the patients are said to…

read more
Contact us